Literature DB >> 20186940

When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations.

Corey A Siegel1, Lisa M Schwartz, Steven Woloshin, Elisabeth B Cole, David T Rubin, Tegan Vay, Judith Baars, Bruce E Sands.   

Abstract

BACKGROUND: If dysplasia is found on biopsies during surveillance colonoscopy for ulcerative colitis (UC), many experts recommend colectomy given the substantial risk of synchronous colon cancer. The objective was to learn if UC patients' perceptions of their colon cancer risk and if their preferences for elective colectomy match with physicians' recommendations if dysplasia was found.
METHODS: A self-administered written survey included 199 patients with UC for at least 8 years (mean age 49 years, 52% female) who were recruited from Dartmouth-Hitchcock (n = 104) and the University of Chicago (n = 95). The main outcome was the proportion of patients who disagree with physicians' recommendations for colectomy because of dysplasia.
RESULTS: Almost all respondents recognized that UC raised their chance of getting colon cancer. In all, 74% thought it was "unlikely" or "very unlikely" to get colon cancer within the next 10 years and they quantified this risk to be 23%; 60% of patients would refuse a physician's recommendation for elective colectomy if dysplasia was detected, despite being told that they had a 20% risk of having cancer now. On average, these patients would only agree to colectomy if their risk of colon cancer "right now" were at least 73%.
CONCLUSIONS: UC patients recognize their increased risk of colon cancer and undergo frequent surveillance to reduce their risk. Nonetheless, few seem prepared to follow standard recommendations for elective colectomy if dysplasia is found. This may reflect the belief that surveillance alone is sufficient to reduce their colon cancer risk or genuine disagreement about when it is worth undergoing colectomy.

Entities:  

Mesh:

Year:  2010        PMID: 20186940      PMCID: PMC2927807          DOI: 10.1002/ibd.21233

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

1.  Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2004-07       Impact factor: 10.864

Review 2.  Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease.

Authors:  Steven H Itzkowitz; Daniel H Present
Journal:  Inflamm Bowel Dis       Date:  2005-03       Impact factor: 5.325

3.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 4.  Stability of patients' preferences for chemotherapy: the impact of experience.

Authors:  S J Jansen; J Kievit; M A Nooij; A M Stiggelbout
Journal:  Med Decis Making       Date:  2001 Jul-Aug       Impact factor: 2.583

5.  Do patients' evaluations of a future health state change when they actually enter that state?

Authors:  H A Llewellyn-Thomas; H J Sutherland; E C Thiel
Journal:  Med Care       Date:  1993-11       Impact factor: 2.983

6.  A new scale for assessing perceptions of chance: a validation study.

Authors:  S Woloshin; L M Schwartz; S Byram; B Fischhoff; H G Welch
Journal:  Med Decis Making       Date:  2000 Jul-Sep       Impact factor: 2.583

Review 7.  Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.

Authors:  T Thomas; K A Abrams; R J Robinson; J F Mayberry
Journal:  Aliment Pharmacol Ther       Date:  2007-03-15       Impact factor: 8.171

8.  Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.

Authors:  Thomas Ullman; Victoria Croog; Noam Harpaz; David Sachar; Steven Itzkowitz
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

  8 in total
  14 in total

Review 1.  Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative Review.

Authors:  Kendra J Kamp; Kelly Brittain
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

2.  Proximity to disease and perception of utility: physicians' vs patients' assessment of treatment options for ulcerative colitis.

Authors:  Lindsay Kennedy Brown; Akbar K Waljee; Peter D R Higgins; Jennifer F Waljee; Arden M Morris
Journal:  Dis Colon Rectum       Date:  2011-12       Impact factor: 4.585

Review 3.  Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data.

Authors:  Meenakshi Bewtra; F Reed Johnson
Journal:  Patient       Date:  2013       Impact factor: 3.883

4.  Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis.

Authors:  Gauree Gupta Konijeti; Mark G Shrime; Ashwin N Ananthakrishnan; Andrew T Chan
Journal:  Gastrointest Endosc       Date:  2013-11-18       Impact factor: 9.427

5.  Chromoendoscopy and Dysplasia Surveillance in Inflammatory Bowel Disease: Past, Present, and Future.

Authors:  Steven Naymagon; Thomas A Ullman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-05

Review 6.  An Update on Surveillance in Ulcerative Colitis.

Authors:  Jimmy K Limdi; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2018-03-07

7.  Clarity and caution in the natural history of low-grade dysplasia in ulcerative colitis.

Authors:  John B Kisiel; Edward V Loftus
Journal:  Am J Gastroenterol       Date:  2015-10       Impact factor: 10.864

8.  Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.

Authors:  Timothy L Zisman; Mary P Bronner; Stephen Rulyak; Kris V Kowdley; Michael Saunders; Scott D Lee; Cynthia Ko; Michael B Kimmey; Allyn Stevens; Josephine Maurer; Teresa A Brentnall
Journal:  Inflamm Bowel Dis       Date:  2012-04-16       Impact factor: 5.325

Review 9.  Inflammatory bowel disease associated neoplasia: A surgeon's perspective.

Authors:  Azah A Althumairi; Mark G Lazarev; Susan L Gearhart
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

10.  Colonoscopy Surveillance and Management of Dysplasia in Inflammatory Bowel Disease.

Authors:  Tonya Kaltenbach; Gisele Leite; Roy Soetikno
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.